BioScale Secures $25M for Commercialization of Acoustic-Based Protein Analytics System

The system, which is the eight-year-old company's first product release, uses BioScale's proprietary Acoustic Membrane MicroParticle, or AMMP, technology to offer label-free, non-optical protein detection and quantitation.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.